> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Clears Ventripoint Diagnostics for Heart Function Analyzer
- URL: https://www.fdaweb.com/fda-clears-ventripoint-diagnostics-for-heart-function-analyzer/
- Published: 2018-05-16T12:00:00.000Z
- Updated: 2026-09-15T00:05:28.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5141462

FDA has cleared a Ventripoint Diagnostics 510(k) for its VMS+ machine with a four-chamber heart analysis system, intended for use in the analysis of ejection fraction (function) and volumes in any chamber of the heart. “The VMS+ is the first simple echocardiography system to be approved by the FDA for the 3D volumetric analysis of all four chambers of the heart using 2D ultrasound,” the company says. The heart function analyses are intended for patients with heart failure, abnormal heart rhythms, congenital heart disease, pulmonary hypertension and hypertension, it adds.